ChromaDex (CDXC) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
ChromaDex Corporation Reports First Quarter 2019 Financial Results
May 9, 2019 4:01 PM EDT- First Quarter 2019 Net Revenues Increased by 53% to $10.0 Million -
First Quarter 2019 Highlights vs. First Quarter 2018
Strong start to the year with $10.0 million of net sales, higher gross margins and increased marketing efficiencyContinued progress building TRU NIAGEN into a global brand with top-line momentumTRU NIAGEN net sales were $7.5 million, a 15% increase sequentially and a 146% increase year-over-yearGlobal expansion continued with e-Commerce roll-out in Canada. Set foundation for initial Canadian retail launch with Showcase and WELL Health Technologies in AprilLOS ANGELES, May 09, 2019 (GLOBE NEWSWIRE)... More
